CompletedNot Applicable

Standardized CEUS Algorithms for Diagnosis of HCC - Prospective German Multicenter Study

Germany517 participantsStarted 2018-04-21

Plain-language summary

Aim of this prospective national multicenter study is to improve standardization of contrast-enhanced ultrasound (CEUS) in the non-invasive diagnosis of hepatocellular carcinoma (HCC) in high-risk patients. The study is funded by the German Society for Ultrasound in Medicine (DEGUM).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * high risk for HCC * focal liver lesion on B-mode ultrasound Exclusion Criteria: * pre-treated HCC lesion * systemic therapy for HCC (sorafenib, regorafenib and others)

What they're measuring

Diagnostic value of standardised CEUS-based algorithms for the non-invasive diagnosis of HCC in high-risk patients

Timeframe: 2 years

Trial details

NCT IDNCT03405909

SponsorUniversity Hospital Erlangen

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-04-06

View on ClinicalTrials.gov More Hepatocellular Carcinoma trials